STOCK TITAN

[Form 4] Repligen Corp Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Repligen Corp (RGEN) insider transaction summary. Olivier Loeillot, who serves as both Director and Chief Executive Officer, reported a transaction dated 09/03/2025 showing 2,506 shares of Repligen common stock were disposed of at a price of $116.18 per share. The filing explains these shares were withheld by the issuer to satisfy tax withholding obligations arising upon the release of restricted stock units. After the withholding, Loeillot beneficially owns 44,187 shares outright. The Form 4 was filed by one reporting person and signed on behalf of Loeillot by Jennifer Carmichael (Attorney in Fact) on 09/04/2025.

Riepilogo dell'operazione interna di Repligen Corp (RGEN). Olivier Loeillot, che ricopre le cariche di amministratore e amministratore delegato, ha segnalato un'operazione in data 09/03/2025 in cui 2.506 azioni ordinarie Repligen sono state cedute al prezzo di $116.18 per azione. La comunicazione specifica che queste azioni sono state trattenute dall'emittente per soddisfare obblighi di ritenuta fiscale derivanti dalla maturazione e rilascio di restricted stock units. Dopo la ritenuta, Loeillot possiede beneficiariamente 44.187 azioni in proprietà diretta. Il Form 4 è stato presentato da una persona che effettua la comunicazione e firmato per conto di Loeillot da Jennifer Carmichael (procuratore) il 09/04/2025.

Resumen de la operación interna de Repligen Corp (RGEN). Olivier Loeillot, que ejerce como Director y Director Ejecutivo, informó una operación con fecha 03/09/2025 en la que se disponían 2.506 acciones ordinarias de Repligen a un precio de $116.18 por acción. El documento explica que estas acciones fueron retenidas por el emisor para satisfacer obligaciones de retención fiscal surgidas al liberarse unidades de acciones restringidas (restricted stock units). Tras la retención, Loeillot ostenta beneficiariamente 44.187 acciones en propiedad directa. El Form 4 fue presentado por una sola persona informante y firmado en nombre de Loeillot por Jennifer Carmichael (apoderada) el 04/09/2025.

Repligen Corp (RGEN) 내부자 거래 요약. 이사회 구성원 겸 최고경영자인 Olivier Loeillot는 2025-09-03자 거래를 보고했으며, 해당 보고서에 따르면 Repligen 보통주 2,506주가 주당 $116.18에 처분되었습니다. 제출서에는 이 주식들이 제한주식단위(restricted stock units) 해제 시 발생한 세금 원천징수 의무를 충족하기 위해 발행사가 보류했다고 설명되어 있습니다. 원천징수 후 Loeillot는 44,187주를 실질 소유하고 있습니다. Form 4는 한 명의 신고자가 제출했으며 2025-09-04에 Jennifer Carmichael(위임인)가 Loeillot를 대신해 서명했습니다.

Résumé de la transaction d'initié de Repligen Corp (RGEN). Olivier Loeillot, qui est à la fois administrateur et directeur général, a déclaré une opération datée du 03/09/2025 indiquant que 2 506 actions ordinaires de Repligen ont été cédées au prix de 116,18 $ par action. Le dépôt précise que ces actions ont été retenues par l'émetteur pour satisfaire des obligations de retenue d'impôt nées lors de la libération d'unités d'actions restreintes (restricted stock units). Après cette retenue, Loeillot détient à titre bénéficiaire 44 187 actions en pleine propriété. Le Form 4 a été déposé par une seule personne déclarant et signé pour le compte de Loeillot par Jennifer Carmichael (mandataire) le 04/09/2025.

Zusammenfassung der Insider-Transaktion von Repligen Corp (RGEN). Olivier Loeillot, der sowohl Direktor als auch Chief Executive Officer ist, meldete eine Transaktion vom 03.09.2025, bei der 2.506 Aktien der Repligen-Stammaktien zu einem Preis von $116.18 pro Aktie veräußert wurden. Die Meldung erläutert, dass diese Aktien vom Emittenten einbehalten wurden, um steuerliche Abzugsverpflichtungen im Zusammenhang mit der Freigabe von Restricted Stock Units zu erfüllen. Nach der Einbehaltung besitzt Loeillot wirtschaftlich 44.187 Aktien unmittelbar. Das Form 4 wurde von einer meldepflichtigen Person eingereicht und am 04.09.2025 von Jennifer Carmichael (Bevollmächtigte) im Namen Loeillot unterschrieben.

Positive
  • Insider retains meaningful ownership: Olivier Loeillot continues to beneficially own 44,187 shares after withholding.
  • Transaction is administrative: Shares were withheld to satisfy tax obligations on RSU release, not an open-market sale.
Negative
  • Shares disposed via withholding: 2,506 shares were removed from the insider's direct holdings to cover taxes.

Insights

TL;DR: Routine tax-withholding on RSU release; no change in role or control.

This appears to be a standard administrative disposition where shares were withheld to cover tax obligations when restricted stock units vested. The reporting person remains both CEO and a director and continues to hold a material stake of 44,187 shares directly. There is no indication of a voluntary sale or change in ownership strategy. For governance considerations, routine withholding is common and typically not a signal of insider-driven liquidity or governance shifts.

TL;DR: Transaction is non-economic withholding, not a market sale; impact on float is minimal.

The reported disposition of 2,506 shares at an effective price of $116.18 reflects shares retained by the issuer to satisfy tax withholdings tied to RSU vesting. Because this is a non-market transfer (issuer withholding), it does not reflect active selling pressure from the insider. Post-transaction direct beneficial ownership totals 44,187 shares, which retains insider alignment with shareholders. The event is informational and likely immaterial to short-term share supply dynamics.

Riepilogo dell'operazione interna di Repligen Corp (RGEN). Olivier Loeillot, che ricopre le cariche di amministratore e amministratore delegato, ha segnalato un'operazione in data 09/03/2025 in cui 2.506 azioni ordinarie Repligen sono state cedute al prezzo di $116.18 per azione. La comunicazione specifica che queste azioni sono state trattenute dall'emittente per soddisfare obblighi di ritenuta fiscale derivanti dalla maturazione e rilascio di restricted stock units. Dopo la ritenuta, Loeillot possiede beneficiariamente 44.187 azioni in proprietà diretta. Il Form 4 è stato presentato da una persona che effettua la comunicazione e firmato per conto di Loeillot da Jennifer Carmichael (procuratore) il 09/04/2025.

Resumen de la operación interna de Repligen Corp (RGEN). Olivier Loeillot, que ejerce como Director y Director Ejecutivo, informó una operación con fecha 03/09/2025 en la que se disponían 2.506 acciones ordinarias de Repligen a un precio de $116.18 por acción. El documento explica que estas acciones fueron retenidas por el emisor para satisfacer obligaciones de retención fiscal surgidas al liberarse unidades de acciones restringidas (restricted stock units). Tras la retención, Loeillot ostenta beneficiariamente 44.187 acciones en propiedad directa. El Form 4 fue presentado por una sola persona informante y firmado en nombre de Loeillot por Jennifer Carmichael (apoderada) el 04/09/2025.

Repligen Corp (RGEN) 내부자 거래 요약. 이사회 구성원 겸 최고경영자인 Olivier Loeillot는 2025-09-03자 거래를 보고했으며, 해당 보고서에 따르면 Repligen 보통주 2,506주가 주당 $116.18에 처분되었습니다. 제출서에는 이 주식들이 제한주식단위(restricted stock units) 해제 시 발생한 세금 원천징수 의무를 충족하기 위해 발행사가 보류했다고 설명되어 있습니다. 원천징수 후 Loeillot는 44,187주를 실질 소유하고 있습니다. Form 4는 한 명의 신고자가 제출했으며 2025-09-04에 Jennifer Carmichael(위임인)가 Loeillot를 대신해 서명했습니다.

Résumé de la transaction d'initié de Repligen Corp (RGEN). Olivier Loeillot, qui est à la fois administrateur et directeur général, a déclaré une opération datée du 03/09/2025 indiquant que 2 506 actions ordinaires de Repligen ont été cédées au prix de 116,18 $ par action. Le dépôt précise que ces actions ont été retenues par l'émetteur pour satisfaire des obligations de retenue d'impôt nées lors de la libération d'unités d'actions restreintes (restricted stock units). Après cette retenue, Loeillot détient à titre bénéficiaire 44 187 actions en pleine propriété. Le Form 4 a été déposé par une seule personne déclarant et signé pour le compte de Loeillot par Jennifer Carmichael (mandataire) le 04/09/2025.

Zusammenfassung der Insider-Transaktion von Repligen Corp (RGEN). Olivier Loeillot, der sowohl Direktor als auch Chief Executive Officer ist, meldete eine Transaktion vom 03.09.2025, bei der 2.506 Aktien der Repligen-Stammaktien zu einem Preis von $116.18 pro Aktie veräußert wurden. Die Meldung erläutert, dass diese Aktien vom Emittenten einbehalten wurden, um steuerliche Abzugsverpflichtungen im Zusammenhang mit der Freigabe von Restricted Stock Units zu erfüllen. Nach der Einbehaltung besitzt Loeillot wirtschaftlich 44.187 Aktien unmittelbar. Das Form 4 wurde von einer meldepflichtigen Person eingereicht und am 04.09.2025 von Jennifer Carmichael (Bevollmächtigte) im Namen Loeillot unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Loeillot Olivier

(Last) (First) (Middle)
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100

(Street)
WALTHAM MA 02453

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
REPLIGEN CORP [ RGEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/03/2025 F 2,506(1) D $116.18 44,187 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
/s/ Jennifer Carmichael (Attorney in Fact) 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Olivier Loeillot report for RGEN on 09/03/2025?

He reported that 2,506 shares of Repligen common stock were disposed of via issuer withholding related to RSU tax obligations on 09/03/2025.

Why were the 2,506 shares disposed according to the Form 4?

The Form 4 explains the shares were withheld by the issuer to satisfy tax withholding obligations arising upon the release of restricted stock units.

How many Repligen shares does Loeillot beneficially own after the transaction?

After the withholding, Loeillot beneficially owns 44,187 shares of Repligen common stock.

What price is shown on the Form 4 for the withheld shares?

The Form 4 lists a price of $116.18 per share for the reported disposition.

Who signed the Form 4 and when was it signed?

The Form 4 was signed on behalf of Olivier Loeillot by Jennifer Carmichael (Attorney in Fact) on 09/04/2025.
Repligen

NASDAQ:RGEN

RGEN Rankings

RGEN Latest News

RGEN Latest SEC Filings

RGEN Stock Data

6.78B
52.49M
6.4%
105.1%
6.47%
Medical Instruments & Supplies
Biological Products, (no Disgnostic Substances)
Link
United States
WALTHAM